Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alcoholic hallucinosis]

H Suwaki1, R Miyatake

  • 1Department of Neuropsychiatry, Kagawa Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1997
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crystal structure of S-hexyl (E)-3-(2-hy-droxy-benzyl-idene)di-thio-carbazate.

Acta crystallographica. Section E, Crystallographic communications·2016
Same author

Crystal structure of 1,2-bis-((benzyl-sulfan-yl){2-[1-(2-hy-droxy-phen-yl)ethyl-idene]hydrazin-1-yl-idene}meth-yl)disulfane.

Acta crystallographica. Section E, Crystallographic communications·2016
Same author

Crystal structure of bis-[μ-S-hexyl 3-(2-oxido-benzyl-idene)di-thio-carbazato-κ(4) O,N (3),S:O]dicopper(II).

Acta crystallographica. Section E, Crystallographic communications·2016
Same author

Ethanol metabolism, toxicity and genetic polymorphism.

Addiction biology·2016
Same author

Crystal structure of bis-{S-hexyl 3-[4-(di-methyl-amino)-benzyl-idene]di-thio-carbazato-κ(2) N (3),S}copper(II).

Acta crystallographica. Section E, Crystallographic communications·2015
Same author

Crystal structure of S-octyl (E)-3-(4-meth-oxy-benzyl-idene)di-thio-carbazate.

Acta crystallographica. Section E, Crystallographic communications·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles